Frédéric Pouliot
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 74
- Prostate Cancer Treatment and Research 70
- Prostate Cancer Diagnosis and Treatment 29
-
- Renal and related cancers 14
- Co-authors
- Stéphane Bolduc (10 shared papers)Cassandra Ringuette Goulet (9 shared papers)Stéphane Chabaud (9 shared papers)Geneviève Bernard (5 shared papers)Claude Labrie (4 shared papers)Rustem Gafanov (19 shared papers)Michael B. Atkins (14 shared papers)Denis Soulières (28 shared papers)
- Journals
- Journal of Clinical Oncology (40 papers)The Journal of Urology (18 papers)Urologic Oncology Seminars and Original Investigations (7 papers)Cancers (6 papers)Clinical Genitourinary Cancer (5 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Frédéric Pouliot
189 papers receiving 4.7k citations
Frédéric Pouliot's Hit Papers
Peers
Comparison fields: 5 of 120
- Pulmonary and Respiratory Medicine 2.6k
- Cancer Research 804
- Oncology 1.1k
- Radiology, Nuclear Medicine and Imaging 453
- Molecular Biology 1.4k
Countries citing papers authored by Frédéric Pouliot
This map shows the geographic impact of Frédéric Pouliot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Pouliot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Pouliot more than expected).
Fields of papers citing papers by Frédéric Pouliot
This network shows the impact of papers produced by Frédéric Pouliot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Pouliot. The network helps show where Frédéric Pouliot may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Pouliot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 205 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial Hit paper breakdown → | 2020 | 514 |
| 2 | 2018 | 257 | |
| 3 | A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY) Hit paper breakdown → | 2021 | 255 |
| 4 | Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study Hit paper breakdown → | 2021 | 250 |
| 5 | 2019 | 249 | |
| 6 | Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma Hit paper breakdown → | 2021 | 188 |
| 7 | 2015 | 151 | |
| 8 | 2018 | 132 | |
| 9 | 2010 | 119 | |
| 10 | 2019 | 87 | |
| 11 | 2021 | 76 | |
| 12 | 2002 | 71 | |
| 13 | 2018 | 70 | |
| 14 | Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. | 2003 | 70 |
| 15 | 2023 | 68 | |
| 16 | 2019 | 67 | |
| 17 | 2018 | 66 | |
| 18 | 2018 | 61 | |
| 19 | 2002 | 55 | |
| 20 | 2016 | 49 |
About Frédéric Pouliot
Frédéric Pouliot is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 205 papers that have together received 4.7k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (74 papers), Prostate Cancer Treatment and Research (70 papers), Prostate Cancer Diagnosis and Treatment (29 papers), Radiopharmaceutical Chemistry and Applications (23 papers), Renal and related cancers (14 papers), Cancer Immunotherapy and Biomarkers (14 papers), Cancer Genomics and Diagnostics (13 papers) and Cancer, Lipids, and Metabolism (12 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.6k citations), Cancer Research (804 citations), Oncology (1.1k citations), Radiology, Nuclear Medicine and Imaging (453 citations) and Molecular Biology (1.4k citations). Frédéric Pouliot has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Stéphane Bolduc, Cassandra Ringuette Goulet, Stéphane Chabaud, Geneviève Bernard, Claude Labrie, Rustem Gafanov, Michael B. Atkins, Denis Soulières, Audrey Champagne and Arie S. Belldegrun. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Urologic Oncology Seminars and Original Investigations, Cancers and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.